These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


107 related items for PubMed ID: 2539013

  • 1. Morphologic and cytochemical characteristics of acute promyelocytic leukemia.
    Davey FR, Davis RB, MacCallum JM, Nelson DA, Mayer RJ, Ball ED, Griffin JD, Schiffer CA, Bloomfield CD.
    Am J Hematol; 1989 Apr; 30(4):221-7. PubMed ID: 2539013
    [Abstract] [Full Text] [Related]

  • 2. Nonspecific esterase of acute promyelocytic leukemia (M3).
    Matsuo T, Jain NC, Bennett JM.
    Am J Hematol; 1988 Nov; 29(3):148-51. PubMed ID: 3189310
    [Abstract] [Full Text] [Related]

  • 3. Acute promyelocytic leukemia: morphological aspects.
    Castoldi GL, Liso V, Specchia G, Tomasi P.
    Leukemia; 1994 Sep; 8(9):1441-6. PubMed ID: 8090023
    [Abstract] [Full Text] [Related]

  • 4. Cytochemical and immunophenotypic heterogeneity in acute promyelocytic leukemia.
    Das Gupta A, Sapre RS, Shah AS, Advani SH, Nair CN.
    Acta Haematol; 1989 Sep; 81(1):5-9. PubMed ID: 2467498
    [Abstract] [Full Text] [Related]

  • 5. Short-term treatment for adult hypergranular and microgranular acute promyelocytic leukemia.
    Bassan R, Battista R, Viero P, d'Emilio A, Buelli M, Montaldi A, Rambaldi A, Tremul L, Dini E, Barbui T.
    Leukemia; 1995 Feb; 9(2):238-43. PubMed ID: 7869758
    [Abstract] [Full Text] [Related]

  • 6. The biological characteristics of CD34+ CD2+ adult acute promyelocytic leukemia and the CD34 CD2 hypergranular (M3) and microgranular (M3v) phenotypes.
    Albano F, Mestice A, Pannunzio A, Lanza F, Martino B, Pastore D, Ferrara F, Carluccio P, Nobile F, Castoldi G, Liso V, Specchia G.
    Haematologica; 2006 Mar; 91(3):311-6. PubMed ID: 16531253
    [Abstract] [Full Text] [Related]

  • 7. Acute promyelocytic leukemia: morphological aspects.
    Castoldi GL, Liso V, Specchia G, Tomasi P.
    Leukemia; 1994 Mar; 8 Suppl 2():S27-32. PubMed ID: 7815833
    [Abstract] [Full Text] [Related]

  • 8. Microgranular variant of acute promyelocytic leukemia in children.
    Rovelli A, Biondi A, Cantù Rajnoldi A, Conter V, Giudici G, Jankovic M, Locasciulli A, Rizzari C, Romitti L, Rossi MR.
    J Clin Oncol; 1992 Sep; 10(9):1413-8. PubMed ID: 1517784
    [Abstract] [Full Text] [Related]

  • 9. Cytochemical stainings in acute promyelocytic leukemia: chloroacetate esterase reaction as a prognostic index.
    Chinprasertsuk S, Piankijagum A, Issaragrisil S.
    J Med Assoc Thai; 1991 Feb; 74(2):87-91. PubMed ID: 1647435
    [Abstract] [Full Text] [Related]

  • 10. CD2 expression in acute promyelocytic leukemia is associated with microgranular morphology (FAB M3v) but not with any PML gene breakpoint.
    Biondi A, Luciano A, Bassan R, Mininni D, Specchia G, Lanzi E, Castagna S, Cantù-Rajnoldi A, Liso V, Masera G.
    Leukemia; 1995 Sep; 9(9):1461-6. PubMed ID: 7658712
    [Abstract] [Full Text] [Related]

  • 11. Cytochemistry of acute promyelocytic leukemia (M3): leukemic promyelocytes exhibit heterogeneous patterns in cellular differentiation.
    Tomonaga M, Yoshida Y, Tagawa M, Jinnai I, Kuriyama K, Amenomori T, Yoshioka A, Matsuo T, Nonaka H, Ichimaru M.
    Blood; 1985 Aug; 66(2):350-7. PubMed ID: 2410066
    [Abstract] [Full Text] [Related]

  • 12. Correlation between morphological and cytochemical heterogeneity of acute promyelocytic leukemia (APL) and its association with myelodysplasia.
    Varma N, Dash S, Sarode R.
    Indian J Cancer; 1990 Sep; 27(3):165-71. PubMed ID: 2090569
    [Abstract] [Full Text] [Related]

  • 13. Cytochemical reactions in cells from leukemic dogs.
    Grindem CB, Stevens JB, Perman V.
    Vet Pathol; 1986 Mar; 23(2):103-9. PubMed ID: 3962077
    [Abstract] [Full Text] [Related]

  • 14. Quantitative enzyme determination in acute myeloid leukemia.
    Ossenkoppele GJ, Wijermans PJ, Huijgens PC, Nauta JJ, Langenhuijsen MM.
    Leuk Res; 1991 Mar; 15(6):481-6. PubMed ID: 1650411
    [Abstract] [Full Text] [Related]

  • 15. Immunophenotypic and enzymatic studies do not support the concept of mixed monocytic-granulocytic differentiation in acute promyelocytic leukaemia (M3): a study of 44 cases.
    Scott CS, Patel D, Drexler HG, Master PS, Limbert HJ, Roberts BE.
    Br J Haematol; 1989 Apr; 71(4):505-9. PubMed ID: 2653408
    [Abstract] [Full Text] [Related]

  • 16. Expression of CD2 in acute promyelocytic leukemia correlates with short form of PML-RARalpha transcripts and poorer prognosis.
    Lin P, Hao S, Medeiros LJ, Estey EH, Pierce SA, Wang X, Glassman AB, Bueso-Ramos C, Huh YO.
    Am J Clin Pathol; 2004 Mar; 121(3):402-7. PubMed ID: 15023045
    [Abstract] [Full Text] [Related]

  • 17. Leukemias resembling acute promyelocytic leukemia, microgranular variant.
    Nagendra S, Meyerson H, Skallerud G, Rosenthal N.
    Am J Clin Pathol; 2002 Apr; 117(4):651-7. PubMed ID: 11939742
    [Abstract] [Full Text] [Related]

  • 18. Acute promyelocytic leukemia: clinical and morphologic features and prognostic factors.
    Avvisati G, Lo Coco F, Mandelli F.
    Semin Hematol; 2001 Jan; 38(1):4-12. PubMed ID: 11172535
    [Abstract] [Full Text] [Related]

  • 19. A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes.
    Paietta E, Goloubeva O, Neuberg D, Bennett JM, Gallagher R, Racevskis J, Dewald G, Wiernik PH, Tallman MS, Eastern Cooperative Oncology Group.
    Cytometry B Clin Cytom; 2004 May; 59(1):1-9. PubMed ID: 15108165
    [Abstract] [Full Text] [Related]

  • 20. Clinicopathological features of acute promyelocytic leukemia: an experience in one institute emphasizing the morphological and immunophenotypic changes at the time of relapse.
    Yoshii M, Ishida M, Yoshida T, Okuno H, Nakanishi R, Horinouchi A, Hodohara K, Okabe H.
    Int J Clin Exp Pathol; 2013 May; 6(10):2192-8. PubMed ID: 24133598
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.